MOSCOW, 13 APR — RIA Novosti. Japanese doctors have previously found that nelfinavir blocks the replication of the coronavirus SARS-CoV-2. The study is published in the portal preprints and bioRxiv.
Nelfinavir is used against human immunodeficiency virus. In the treatment of HIV-this medication is used in combination with other antiretroviral drugs.
the Researchers studied the effect of nine of these drugs into particles of the new coronavirus and found a pattern in the use of nelfinavir and reduced the replication activity of the pathogen COVID-19.
Doctors said that the proven tools against coronavirus infection had not been invented, so it is necessary to test effective antiviral drugs.
the world health organization on 11 March announced the outbreak of a new coronavirus infection COVID-19 pandemic. According to the latest who data, the world recorded almost 1.7 million infections, more than 105 thousand people died.
the Latest data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.
